These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3267)

  • 1. Importance of O-methylation in dopamine-induced motor and behavioral phenomena.
    Furgeson MD; Dill RE; Dorris RL
    Brain Res; 1976 Mar; 105(1):163-7. PubMed ID: 3267
    [No Abstract]   [Full Text] [Related]  

  • 2. An experimental model of tardive dyskinesia.
    Klawans HL; Rubovits R
    J Neural Transm; 1972; 33(3):235-46. PubMed ID: 4674512
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior.
    Weiner WJ; Goetz C; Westheimer R; Klawans HL
    J Neurol Sci; 1973 Dec; 20(4):373-9. PubMed ID: 4359068
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects on precise motor responding of bilateral intrastriatal application of dopamine.
    Butcher LL; Gan J
    Behav Biol; 1974 Dec; 12(4):533-9. PubMed ID: 4476209
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of chronic administration of neuroleptics: dyskinesias in monkeys.
    Paulson G
    Pharmacol Ther B; 1976; 2(1):167-71. PubMed ID: 4829
    [No Abstract]   [Full Text] [Related]  

  • 6. Paramethoxyphenylethylamine (PMPEA): some behavioral observations in rats.
    Cannon HE; Staub RA; Wyatt RJ; Gillin JC
    Commun Psychopharmacol; 1977; 1(1):71-9. PubMed ID: 564254
    [No Abstract]   [Full Text] [Related]  

  • 7. The behavioral effects of D-amphetamine are correlated with its effects on cAMP in different brain regions.
    Kennedy LA; Zigmond MJ
    Brain Res; 1979 May; 168(2):408-13. PubMed ID: 221074
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioral effects of unilateral dopamine injection into dorsal or ventral striatum.
    Joyce JN; Davis RE; Van Hartesveldt C
    Eur J Pharmacol; 1981 Jun; 72(1):1-10. PubMed ID: 7196334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evaluation of clomacran, a new potent psychotropic agent.
    Fowler PJ; Zirkle CL; Macko E; Kaiser C; Sarau H; Tedeschi DH
    Arzneimittelforschung; 1977; 27(4):866-72. PubMed ID: 17419
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral and biochemical effects of amperozide and serotonin agents on nigrostriatal and mesolimbic dopamine systems.
    Chang PY; Chuang CH; Chen JC; Tung CS
    Chin J Physiol; 2008 Apr; 51(2):106-15. PubMed ID: 18666714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous and amphetamine-induced behavior after bilateral injection of ethanolamine-O-sulfate into the substantia nigra.
    Koob GF; Del Fiacco M; Iversen SD
    Brain Res; 1978 May; 146(2):313-23. PubMed ID: 565665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of anticholinergic drugs on striatal dopamine.
    Snyder SH
    Pharmacol Ther B; 1976; 2(1):65-70. PubMed ID: 772723
    [No Abstract]   [Full Text] [Related]  

  • 13. Cocaine-induced behavioral sensitization and D1 dopamine receptor function in rat nucleus accumbens and striatum.
    Mayfield RD; Larson G; Zahniser NR
    Brain Res; 1992 Feb; 573(2):331-5. PubMed ID: 1387030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH; Smee ML; Woolston ME
    Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
    [No Abstract]   [Full Text] [Related]  

  • 16. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antipsychotic drug modification of motor hyperactivity and stereotyped behavior induced by amphetamine in rats with lesions in the nigrostriatal and mesolymbic dopaminergic systems].
    Sánchez-Blázquez P; Fernández-Tomé MP; Fuentes JA; del Río J
    Arch Farmacol Toxicol; 1978 Apr; 4(1):66-8. PubMed ID: 29574
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD; Creese I
    Adv Neurol; 1975; 9():81-92. PubMed ID: 1170717
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
    Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ
    Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrastriatal injection of [3H]dopamine through a chronic cannula to produce rotation: distribution and concentration of the tracer in specific brain regions.
    Wolfson LI; Brown LL
    Brain Res; 1983 Feb; 261(2):205-12. PubMed ID: 6831208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.